INTS8 inhibitors are chemical compounds that selectively target the INTS8 protein, a subunit of the Integrator complex. This complex is a large, multi-protein assembly involved in the regulation of gene expression, particularly through the processing and termination of small nuclear RNAs (snRNAs) and the modulation of transcription from RNA polymerase II. INTS8 plays a structural and regulatory role within the Integrator complex, and inhibitors of INTS8 are designed to interfere with these functions, disrupting the complex's ability to process RNA effectively. Such inhibition can lead to alterations in transcriptional regulation, splicing events, and other post-transcriptional modifications essential for the correct expression and maturation of RNA molecules.
These inhibitors typically function by binding to INTS8 directly or by affecting its interaction with other subunits of the Integrator complex. This interference can impede the structural integrity of the complex, leading to downstream effects on cellular RNA handling and gene expression. INTS8 inhibitors are often studied to explore the molecular mechanisms of RNA processing, transcription regulation, and to understand how the Integrator complex modulates different gene expression pathways. Since the Integrator complex is crucial for maintaining proper cellular function, chemical compounds targeting INTS8 provide valuable insights into the roles that this protein and its associated complex play in both normal cellular physiology and broader biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA Polymerase II (Pol II), potentially affecting snRNA processing and integrator complex activity. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Impacts transcription elongation by Pol II, potentially influencing integrator complex functions. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Cyclin-dependent kinase inhibitor, affecting transcription regulation, possibly impacting INTS8. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
Selective inhibitor of histone deacetylase 3 (HDAC3), could indirectly affect transcription and INTS8 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor, potentially influencing chromatin structure and impacting integrator complex activity. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Broad HDAC inhibitor, may affect chromatin structure and transcription, indirectly impacting INTS8. | ||||||
CPI-203 | 1446144-04-2 | sc-501599 | 1 mg | $170.00 | ||
Inhibits CREB binding protein (CBP)/p300, could influence transcription regulation and INTS8 function. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Inhibits BET bromodomain proteins, potentially affecting transcription and thus INTS8 activity. | ||||||
THZ1 | 1604810-83-4 | sc-507542 | 1 mg | $95.00 | ||
CDK7 inhibitor, affecting transcription initiation and elongation, may impact INTS8. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Inhibits the spliceosome, potentially affecting processes relevant to INTS8. | ||||||